nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—ABCB1—colon cancer	0.152	1	CbGaD
Cyclosporine—ABCC10—Vincristine—colon cancer	0.0601	0.105	CbGbCtD
Cyclosporine—ABCC3—Fluorouracil—colon cancer	0.0415	0.0724	CbGbCtD
Cyclosporine—ABCC3—Vincristine—colon cancer	0.0378	0.066	CbGbCtD
Cyclosporine—ABCC10—Methotrexate—colon cancer	0.0364	0.0635	CbGbCtD
Cyclosporine—ABCB11—Vincristine—colon cancer	0.0327	0.057	CbGbCtD
Cyclosporine—ABCC1—Irinotecan—colon cancer	0.0265	0.0463	CbGbCtD
Cyclosporine—ABCC1—Vincristine—colon cancer	0.0232	0.0405	CbGbCtD
Cyclosporine—ABCC3—Methotrexate—colon cancer	0.0229	0.0399	CbGbCtD
Cyclosporine—SLCO1B1—Irinotecan—colon cancer	0.0224	0.039	CbGbCtD
Cyclosporine—ABCC2—Irinotecan—colon cancer	0.0196	0.0343	CbGbCtD
Cyclosporine—ABCG2—Irinotecan—colon cancer	0.0178	0.031	CbGbCtD
Cyclosporine—ABCC2—Vincristine—colon cancer	0.0172	0.03	CbGbCtD
Cyclosporine—ABCG2—Fluorouracil—colon cancer	0.017	0.0298	CbGbCtD
Cyclosporine—ABCG2—Vincristine—colon cancer	0.0155	0.0271	CbGbCtD
Cyclosporine—ABCC1—Methotrexate—colon cancer	0.014	0.0245	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0131	0.0229	CbGbCtD
Cyclosporine—CYP3A7—Irinotecan—colon cancer	0.0131	0.0229	CbGbCtD
Cyclosporine—SLCO1A2—Methotrexate—colon cancer	0.0125	0.0219	CbGbCtD
Cyclosporine—SLCO1B1—Methotrexate—colon cancer	0.0118	0.0207	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0115	0.02	CbGbCtD
Cyclosporine—CYP3A7—Vincristine—colon cancer	0.0115	0.02	CbGbCtD
Cyclosporine—CYP2C9—Capecitabine—colon cancer	0.0107	0.0187	CbGbCtD
Cyclosporine—ABCC2—Methotrexate—colon cancer	0.0104	0.0182	CbGbCtD
Cyclosporine—SLC10A2—bile—colon cancer	0.0101	0.114	CbGeAlD
Cyclosporine—CYP3A5—Irinotecan—colon cancer	0.00984	0.0172	CbGbCtD
Cyclosporine—ABCG2—Methotrexate—colon cancer	0.0094	0.0164	CbGbCtD
Cyclosporine—CYP2C8—Fluorouracil—colon cancer	0.00908	0.0159	CbGbCtD
Cyclosporine—CYP3A5—Vincristine—colon cancer	0.0086	0.015	CbGbCtD
Cyclosporine—SLC22A6—Methotrexate—colon cancer	0.00761	0.0133	CbGbCtD
Cyclosporine—ABCB1—Irinotecan—colon cancer	0.00641	0.0112	CbGbCtD
Cyclosporine—CYP2C9—Fluorouracil—colon cancer	0.00633	0.0111	CbGbCtD
Cyclosporine—ABCB1—Vincristine—colon cancer	0.0056	0.00977	CbGbCtD
Cyclosporine—SLC10A1—bile—colon cancer	0.00544	0.0618	CbGeAlD
Cyclosporine—ABCB11—bile—colon cancer	0.00538	0.0611	CbGeAlD
Cyclosporine—CYP3A4—Irinotecan—colon cancer	0.00384	0.0067	CbGbCtD
Cyclosporine—ABCB1—Methotrexate—colon cancer	0.00339	0.00592	CbGbCtD
Cyclosporine—CYP3A4—Vincristine—colon cancer	0.00335	0.00586	CbGbCtD
Cyclosporine—ABCC2—bile—colon cancer	0.00274	0.0311	CbGeAlD
Cyclosporine—PPIB—gall bladder—colon cancer	0.00177	0.0201	CbGeAlD
Cyclosporine—FKBP4—embryo—colon cancer	0.00175	0.0199	CbGeAlD
Cyclosporine—SLC10A2—renal system—colon cancer	0.00134	0.0152	CbGeAlD
Cyclosporine—FKBP4—renal system—colon cancer	0.00133	0.0151	CbGeAlD
Cyclosporine—PPID—smooth muscle tissue—colon cancer	0.00127	0.0145	CbGeAlD
Cyclosporine—FKBP1B—liver—colon cancer	0.00123	0.0139	CbGeAlD
Cyclosporine—PPID—renal system—colon cancer	0.00122	0.0139	CbGeAlD
Cyclosporine—FKBP4—lymphoid tissue—colon cancer	0.0011	0.0125	CbGeAlD
Cyclosporine—SLC10A2—digestive system—colon cancer	0.0011	0.0125	CbGeAlD
Cyclosporine—FKBP4—digestive system—colon cancer	0.00109	0.0124	CbGeAlD
Cyclosporine—CAMLG—lymphoid tissue—colon cancer	0.001	0.0114	CbGeAlD
Cyclosporine—SLC10A2—vagina—colon cancer	0.00097	0.011	CbGeAlD
Cyclosporine—ABCC3—gall bladder—colon cancer	0.000951	0.0108	CbGeAlD
Cyclosporine—FKBP1B—lymph node—colon cancer	0.00094	0.0107	CbGeAlD
Cyclosporine—PPID—bone marrow—colon cancer	0.000926	0.0105	CbGeAlD
Cyclosporine—PPIF—smooth muscle tissue—colon cancer	0.000925	0.0105	CbGeAlD
Cyclosporine—PPIB—epithelium—colon cancer	0.000914	0.0104	CbGeAlD
Cyclosporine—CAMLG—bone marrow—colon cancer	0.000913	0.0104	CbGeAlD
Cyclosporine—PPIF—renal system—colon cancer	0.000891	0.0101	CbGeAlD
Cyclosporine—PPID—vagina—colon cancer	0.000887	0.0101	CbGeAlD
Cyclosporine—PPP3CA—smooth muscle tissue—colon cancer	0.000886	0.0101	CbGeAlD
Cyclosporine—PPIB—smooth muscle tissue—colon cancer	0.000881	0.01	CbGeAlD
Cyclosporine—CAMLG—vagina—colon cancer	0.000875	0.00994	CbGeAlD
Cyclosporine—PPP3CA—renal system—colon cancer	0.000853	0.00969	CbGeAlD
Cyclosporine—PPIB—renal system—colon cancer	0.000848	0.00963	CbGeAlD
Cyclosporine—PPIA—bone marrow—colon cancer	0.000832	0.00945	CbGeAlD
Cyclosporine—FKBP4—liver—colon cancer	0.000811	0.00921	CbGeAlD
Cyclosporine—PPIA—vagina—colon cancer	0.000797	0.00905	CbGeAlD
Cyclosporine—PPID—liver—colon cancer	0.000748	0.0085	CbGeAlD
Cyclosporine—CAMLG—liver—colon cancer	0.000738	0.00838	CbGeAlD
Cyclosporine—PPIF—digestive system—colon cancer	0.00073	0.0083	CbGeAlD
Cyclosporine—SLC10A1—renal system—colon cancer	0.000725	0.00824	CbGeAlD
Cyclosporine—PPP3CA—lymphoid tissue—colon cancer	0.000708	0.00804	CbGeAlD
Cyclosporine—PPIB—lymphoid tissue—colon cancer	0.000704	0.008	CbGeAlD
Cyclosporine—PPP3CA—digestive system—colon cancer	0.000699	0.00795	CbGeAlD
Cyclosporine—PPIB—digestive system—colon cancer	0.000695	0.0079	CbGeAlD
Cyclosporine—PPIF—bone marrow—colon cancer	0.000673	0.00765	CbGeAlD
Cyclosporine—PPIA—liver—colon cancer	0.000672	0.00763	CbGeAlD
Cyclosporine—PPIF—vagina—colon cancer	0.000645	0.00733	CbGeAlD
Cyclosporine—PPP3CA—bone marrow—colon cancer	0.000645	0.00732	CbGeAlD
Cyclosporine—PPIB—bone marrow—colon cancer	0.000641	0.00728	CbGeAlD
Cyclosporine—FKBP4—lymph node—colon cancer	0.000622	0.00706	CbGeAlD
Cyclosporine—PPP3CA—vagina—colon cancer	0.000618	0.00702	CbGeAlD
Cyclosporine—PPIB—vagina—colon cancer	0.000614	0.00698	CbGeAlD
Cyclosporine—FKBP1A—epithelium—colon cancer	0.000611	0.00694	CbGeAlD
Cyclosporine—SLC10A1—digestive system—colon cancer	0.000595	0.00676	CbGeAlD
Cyclosporine—FKBP1A—smooth muscle tissue—colon cancer	0.000589	0.00669	CbGeAlD
Cyclosporine—ABCB11—digestive system—colon cancer	0.000588	0.00668	CbGeAlD
Cyclosporine—PPID—lymph node—colon cancer	0.000574	0.00652	CbGeAlD
Cyclosporine—FKBP1A—renal system—colon cancer	0.000567	0.00644	CbGeAlD
Cyclosporine—CAMLG—lymph node—colon cancer	0.000566	0.00643	CbGeAlD
Cyclosporine—PPIF—liver—colon cancer	0.000544	0.00618	CbGeAlD
Cyclosporine—PPP3CA—liver—colon cancer	0.000521	0.00592	CbGeAlD
Cyclosporine—PPIB—liver—colon cancer	0.000518	0.00589	CbGeAlD
Cyclosporine—PPIA—lymph node—colon cancer	0.000515	0.00585	CbGeAlD
Cyclosporine—SLCO1B1—renal system—colon cancer	0.000481	0.00546	CbGeAlD
Cyclosporine—FKBP1A—lymphoid tissue—colon cancer	0.00047	0.00534	CbGeAlD
Cyclosporine—FKBP1A—digestive system—colon cancer	0.000465	0.00528	CbGeAlD
Cyclosporine—ABCC3—renal system—colon cancer	0.000456	0.00518	CbGeAlD
Cyclosporine—ABCC10—renal system—colon cancer	0.000454	0.00516	CbGeAlD
Cyclosporine—SLC10A1—liver—colon cancer	0.000443	0.00503	CbGeAlD
Cyclosporine—ABCB11—liver—colon cancer	0.000438	0.00498	CbGeAlD
Cyclosporine—FKBP1A—bone marrow—colon cancer	0.000428	0.00487	CbGeAlD
Cyclosporine—CYP3A7—liver—colon cancer	0.000428	0.00487	CbGeAlD
Cyclosporine—PPIF—lymph node—colon cancer	0.000417	0.00474	CbGeAlD
Cyclosporine—FKBP1A—vagina—colon cancer	0.00041	0.00466	CbGeAlD
Cyclosporine—PPP3CA—lymph node—colon cancer	0.0004	0.00454	CbGeAlD
Cyclosporine—PPIB—lymph node—colon cancer	0.000397	0.00451	CbGeAlD
Cyclosporine—SLCO1B1—digestive system—colon cancer	0.000394	0.00448	CbGeAlD
Cyclosporine—SLCO1A2—renal system—colon cancer	0.000391	0.00444	CbGeAlD
Cyclosporine—ABCC10—lymphoid tissue—colon cancer	0.000377	0.00428	CbGeAlD
Cyclosporine—ABCC3—digestive system—colon cancer	0.000374	0.00425	CbGeAlD
Cyclosporine—ABCC10—digestive system—colon cancer	0.000372	0.00423	CbGeAlD
Cyclosporine—ABCC2—renal system—colon cancer	0.000364	0.00414	CbGeAlD
Cyclosporine—CYP3A7-CYP3A51P—liver—colon cancer	0.000364	0.00414	CbGeAlD
Cyclosporine—FKBP1A—liver—colon cancer	0.000346	0.00393	CbGeAlD
Cyclosporine—ABCC10—bone marrow—colon cancer	0.000343	0.0039	CbGeAlD
Cyclosporine—ABCC10—vagina—colon cancer	0.000329	0.00373	CbGeAlD
Cyclosporine—SLCO1A2—digestive system—colon cancer	0.000321	0.00365	CbGeAlD
Cyclosporine—ABCC2—digestive system—colon cancer	0.000299	0.0034	CbGeAlD
Cyclosporine—SLCO1B1—liver—colon cancer	0.000294	0.00334	CbGeAlD
Cyclosporine—ABCB1—blood vessel—colon cancer	0.00029	0.0033	CbGeAlD
Cyclosporine—ABCC3—liver—colon cancer	0.000279	0.00317	CbGeAlD
Cyclosporine—ABCC10—liver—colon cancer	0.000277	0.00315	CbGeAlD
Cyclosporine—CYP2C8—renal system—colon cancer	0.000273	0.00311	CbGeAlD
Cyclosporine—FKBP1A—lymph node—colon cancer	0.000265	0.00302	CbGeAlD
Cyclosporine—CYP2C19—digestive system—colon cancer	0.000257	0.00292	CbGeAlD
Cyclosporine—CYP3A5—renal system—colon cancer	0.000247	0.0028	CbGeAlD
Cyclosporine—SLCO1A2—liver—colon cancer	0.000239	0.00272	CbGeAlD
Cyclosporine—ABCC1—vagina—colon cancer	0.000233	0.00264	CbGeAlD
Cyclosporine—CYP2C19—vagina—colon cancer	0.000227	0.00258	CbGeAlD
Cyclosporine—ABCC2—liver—colon cancer	0.000223	0.00253	CbGeAlD
Cyclosporine—ABCC3—lymph node—colon cancer	0.000214	0.00243	CbGeAlD
Cyclosporine—ABCC10—lymph node—colon cancer	0.000213	0.00242	CbGeAlD
Cyclosporine—CYP3A5—digestive system—colon cancer	0.000202	0.0023	CbGeAlD
Cyclosporine—ABCG2—bone marrow—colon cancer	0.000201	0.00228	CbGeAlD
Cyclosporine—CYP2C9—digestive system—colon cancer	0.000199	0.00226	CbGeAlD
Cyclosporine—CYP2C8—vagina—colon cancer	0.000198	0.00225	CbGeAlD
Cyclosporine—ABCC1—liver—colon cancer	0.000196	0.00223	CbGeAlD
Cyclosporine—ABCG2—vagina—colon cancer	0.000192	0.00219	CbGeAlD
Cyclosporine—CYP2C19—liver—colon cancer	0.000191	0.00217	CbGeAlD
Cyclosporine—CYP3A4—renal system—colon cancer	0.000185	0.0021	CbGeAlD
Cyclosporine—CYP2D6—renal system—colon cancer	0.000182	0.00207	CbGeAlD
Cyclosporine—CYP3A5—vagina—colon cancer	0.000179	0.00203	CbGeAlD
Cyclosporine—ABCB1—embryo—colon cancer	0.000173	0.00197	CbGeAlD
Cyclosporine—ABCC2—lymph node—colon cancer	0.000171	0.00194	CbGeAlD
Cyclosporine—CYP2C8—liver—colon cancer	0.000167	0.0019	CbGeAlD
Cyclosporine—ABCG2—liver—colon cancer	0.000162	0.00184	CbGeAlD
Cyclosporine—CYP3A4—digestive system—colon cancer	0.000152	0.00173	CbGeAlD
Cyclosporine—CYP3A5—liver—colon cancer	0.000151	0.00171	CbGeAlD
Cyclosporine—ABCC1—lymph node—colon cancer	0.00015	0.00171	CbGeAlD
Cyclosporine—CYP2D6—digestive system—colon cancer	0.000149	0.0017	CbGeAlD
Cyclosporine—CYP2C9—liver—colon cancer	0.000148	0.00169	CbGeAlD
Cyclosporine—Renal failure—Capecitabine—colon cancer	0.000144	0.00124	CcSEcCtD
Cyclosporine—Discomfort—Irinotecan—colon cancer	0.000144	0.00124	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Capecitabine—colon cancer	0.000143	0.00123	CcSEcCtD
Cyclosporine—Myocardial infarction—Capecitabine—colon cancer	0.000143	0.00123	CcSEcCtD
Cyclosporine—Oedema—Vincristine—colon cancer	0.000143	0.00123	CcSEcCtD
Cyclosporine—Anaphylactic shock—Vincristine—colon cancer	0.000143	0.00123	CcSEcCtD
Cyclosporine—Jaundice—Capecitabine—colon cancer	0.000143	0.00123	CcSEcCtD
Cyclosporine—Stomatitis—Capecitabine—colon cancer	0.000143	0.00123	CcSEcCtD
Cyclosporine—Infection—Vincristine—colon cancer	0.000142	0.00122	CcSEcCtD
Cyclosporine—Urinary tract infection—Capecitabine—colon cancer	0.000142	0.00122	CcSEcCtD
Cyclosporine—Conjunctivitis—Capecitabine—colon cancer	0.000142	0.00122	CcSEcCtD
Cyclosporine—Convulsion—Fluorouracil—colon cancer	0.000142	0.00122	CcSEcCtD
Cyclosporine—ABCB1—epithelium—colon cancer	0.000141	0.00161	CbGeAlD
Cyclosporine—Osteoarthritis—Methotrexate—colon cancer	0.000141	0.00122	CcSEcCtD
Cyclosporine—Confusional state—Irinotecan—colon cancer	0.00014	0.00121	CcSEcCtD
Cyclosporine—Nervous system disorder—Vincristine—colon cancer	0.00014	0.00121	CcSEcCtD
Cyclosporine—Thrombocytopenia—Vincristine—colon cancer	0.00014	0.00121	CcSEcCtD
Cyclosporine—Haematuria—Capecitabine—colon cancer	0.000139	0.0012	CcSEcCtD
Cyclosporine—Anaphylactic shock—Irinotecan—colon cancer	0.000139	0.0012	CcSEcCtD
Cyclosporine—Oedema—Irinotecan—colon cancer	0.000139	0.0012	CcSEcCtD
Cyclosporine—Chest pain—Fluorouracil—colon cancer	0.000139	0.0012	CcSEcCtD
Cyclosporine—Myalgia—Fluorouracil—colon cancer	0.000139	0.0012	CcSEcCtD
Cyclosporine—Infection—Irinotecan—colon cancer	0.000138	0.00119	CcSEcCtD
Cyclosporine—Hyperhidrosis—Vincristine—colon cancer	0.000138	0.00119	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Capecitabine—colon cancer	0.000138	0.00119	CcSEcCtD
Cyclosporine—Epistaxis—Capecitabine—colon cancer	0.000138	0.00119	CcSEcCtD
Cyclosporine—Discomfort—Fluorouracil—colon cancer	0.000138	0.00118	CcSEcCtD
Cyclosporine—Nervous system disorder—Irinotecan—colon cancer	0.000137	0.00118	CcSEcCtD
Cyclosporine—Thrombocytopenia—Irinotecan—colon cancer	0.000136	0.00117	CcSEcCtD
Cyclosporine—Anorexia—Vincristine—colon cancer	0.000136	0.00117	CcSEcCtD
Cyclosporine—Hyperhidrosis—Irinotecan—colon cancer	0.000135	0.00116	CcSEcCtD
Cyclosporine—Confusional state—Fluorouracil—colon cancer	0.000135	0.00116	CcSEcCtD
Cyclosporine—Mood swings—Methotrexate—colon cancer	0.000134	0.00115	CcSEcCtD
Cyclosporine—Anaphylactic shock—Fluorouracil—colon cancer	0.000133	0.00115	CcSEcCtD
Cyclosporine—Oedema—Fluorouracil—colon cancer	0.000133	0.00115	CcSEcCtD
Cyclosporine—Anorexia—Irinotecan—colon cancer	0.000133	0.00114	CcSEcCtD
Cyclosporine—Infection—Fluorouracil—colon cancer	0.000133	0.00114	CcSEcCtD
Cyclosporine—Haemoglobin—Capecitabine—colon cancer	0.000132	0.00114	CcSEcCtD
Cyclosporine—Rhinitis—Capecitabine—colon cancer	0.000132	0.00113	CcSEcCtD
Cyclosporine—Hepatitis—Capecitabine—colon cancer	0.000131	0.00113	CcSEcCtD
Cyclosporine—Haemorrhage—Capecitabine—colon cancer	0.000131	0.00113	CcSEcCtD
Cyclosporine—ABCB1—renal system—colon cancer	0.000131	0.00149	CbGeAlD
Cyclosporine—Nervous system disorder—Fluorouracil—colon cancer	0.000131	0.00113	CcSEcCtD
Cyclosporine—Thrombocytopenia—Fluorouracil—colon cancer	0.000131	0.00112	CcSEcCtD
Cyclosporine—Hypoaesthesia—Capecitabine—colon cancer	0.000131	0.00112	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00013	0.00112	CcSEcCtD
Cyclosporine—Pharyngitis—Capecitabine—colon cancer	0.00013	0.00112	CcSEcCtD
Cyclosporine—Urinary tract disorder—Capecitabine—colon cancer	0.00013	0.00112	CcSEcCtD
Cyclosporine—Insomnia—Vincristine—colon cancer	0.000129	0.00111	CcSEcCtD
Cyclosporine—Connective tissue disorder—Capecitabine—colon cancer	0.000129	0.00111	CcSEcCtD
Cyclosporine—Urethral disorder—Capecitabine—colon cancer	0.000129	0.00111	CcSEcCtD
Cyclosporine—Paraesthesia—Vincristine—colon cancer	0.000128	0.00111	CcSEcCtD
Cyclosporine—Breast disorder—Methotrexate—colon cancer	0.000128	0.0011	CcSEcCtD
Cyclosporine—Anorexia—Fluorouracil—colon cancer	0.000127	0.00109	CcSEcCtD
Cyclosporine—Visual impairment—Capecitabine—colon cancer	0.000126	0.00109	CcSEcCtD
Cyclosporine—Insomnia—Irinotecan—colon cancer	0.000126	0.00108	CcSEcCtD
Cyclosporine—Paraesthesia—Irinotecan—colon cancer	0.000125	0.00108	CcSEcCtD
Cyclosporine—ABCG2—lymph node—colon cancer	0.000125	0.00141	CbGeAlD
Cyclosporine—Decreased appetite—Vincristine—colon cancer	0.000124	0.00107	CcSEcCtD
Cyclosporine—Dyspnoea—Irinotecan—colon cancer	0.000124	0.00107	CcSEcCtD
Cyclosporine—Somnolence—Irinotecan—colon cancer	0.000124	0.00107	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Vincristine—colon cancer	0.000124	0.00106	CcSEcCtD
Cyclosporine—Fatigue—Vincristine—colon cancer	0.000123	0.00106	CcSEcCtD
Cyclosporine—Dyspepsia—Irinotecan—colon cancer	0.000123	0.00106	CcSEcCtD
Cyclosporine—Tinnitus—Capecitabine—colon cancer	0.000122	0.00105	CcSEcCtD
Cyclosporine—Pain—Vincristine—colon cancer	0.000122	0.00105	CcSEcCtD
Cyclosporine—Constipation—Vincristine—colon cancer	0.000122	0.00105	CcSEcCtD
Cyclosporine—Flushing—Capecitabine—colon cancer	0.000122	0.00105	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000122	0.00105	CcSEcCtD
Cyclosporine—Decreased appetite—Irinotecan—colon cancer	0.000121	0.00104	CcSEcCtD
Cyclosporine—Insomnia—Fluorouracil—colon cancer	0.000121	0.00104	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00012	0.00104	CcSEcCtD
Cyclosporine—Fatigue—Irinotecan—colon cancer	0.00012	0.00103	CcSEcCtD
Cyclosporine—Paraesthesia—Fluorouracil—colon cancer	0.00012	0.00103	CcSEcCtD
Cyclosporine—Pancreatitis—Methotrexate—colon cancer	0.00012	0.00103	CcSEcCtD
Cyclosporine—Constipation—Irinotecan—colon cancer	0.000119	0.00103	CcSEcCtD
Cyclosporine—Pain—Irinotecan—colon cancer	0.000119	0.00103	CcSEcCtD
Cyclosporine—Angiopathy—Capecitabine—colon cancer	0.000119	0.00102	CcSEcCtD
Cyclosporine—Dyspnoea—Fluorouracil—colon cancer	0.000119	0.00102	CcSEcCtD
Cyclosporine—Somnolence—Fluorouracil—colon cancer	0.000119	0.00102	CcSEcCtD
Cyclosporine—Mediastinal disorder—Capecitabine—colon cancer	0.000118	0.00102	CcSEcCtD
Cyclosporine—Chills—Capecitabine—colon cancer	0.000118	0.00101	CcSEcCtD
Cyclosporine—Dyspepsia—Fluorouracil—colon cancer	0.000117	0.00101	CcSEcCtD
Cyclosporine—Arrhythmia—Capecitabine—colon cancer	0.000117	0.00101	CcSEcCtD
Cyclosporine—Abdominal discomfort—Methotrexate—colon cancer	0.000117	0.00101	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Vincristine—colon cancer	0.000117	0.00101	CcSEcCtD
Cyclosporine—Decreased appetite—Fluorouracil—colon cancer	0.000116	0.000998	CcSEcCtD
Cyclosporine—Alopecia—Capecitabine—colon cancer	0.000116	0.000998	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000115	0.000991	CcSEcCtD
Cyclosporine—Mental disorder—Capecitabine—colon cancer	0.000115	0.00099	CcSEcCtD
Cyclosporine—Feeling abnormal—Irinotecan—colon cancer	0.000115	0.000988	CcSEcCtD
Cyclosporine—Malnutrition—Capecitabine—colon cancer	0.000114	0.000983	CcSEcCtD
Cyclosporine—Dysuria—Methotrexate—colon cancer	0.000114	0.000982	CcSEcCtD
Cyclosporine—Pain—Fluorouracil—colon cancer	0.000114	0.000982	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Irinotecan—colon cancer	0.000114	0.000981	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Methotrexate—colon cancer	0.000113	0.000976	CcSEcCtD
Cyclosporine—CYP3A4—liver—colon cancer	0.000113	0.00129	CbGeAlD
Cyclosporine—Abdominal pain—Vincristine—colon cancer	0.000113	0.000973	CcSEcCtD
Cyclosporine—Body temperature increased—Vincristine—colon cancer	0.000113	0.000973	CcSEcCtD
Cyclosporine—Flatulence—Capecitabine—colon cancer	0.000113	0.000969	CcSEcCtD
Cyclosporine—Dysgeusia—Capecitabine—colon cancer	0.000112	0.000963	CcSEcCtD
Cyclosporine—CYP2D6—liver—colon cancer	0.000111	0.00126	CbGeAlD
Cyclosporine—Body temperature increased—Irinotecan—colon cancer	0.00011	0.000948	CcSEcCtD
Cyclosporine—Abdominal pain—Irinotecan—colon cancer	0.00011	0.000948	CcSEcCtD
Cyclosporine—Feeling abnormal—Fluorouracil—colon cancer	0.00011	0.000946	CcSEcCtD
Cyclosporine—Muscle spasms—Capecitabine—colon cancer	0.00011	0.000945	CcSEcCtD
Cyclosporine—Pneumonia—Methotrexate—colon cancer	0.000109	0.000942	CcSEcCtD
Cyclosporine—Infestation NOS—Methotrexate—colon cancer	0.000109	0.000937	CcSEcCtD
Cyclosporine—Infestation—Methotrexate—colon cancer	0.000109	0.000937	CcSEcCtD
Cyclosporine—ABCB1—lymphoid tissue—colon cancer	0.000109	0.00124	CbGeAlD
Cyclosporine—Depression—Methotrexate—colon cancer	0.000109	0.000934	CcSEcCtD
Cyclosporine—Vision blurred—Capecitabine—colon cancer	0.000108	0.000927	CcSEcCtD
Cyclosporine—ABCB1—digestive system—colon cancer	0.000107	0.00122	CbGeAlD
Cyclosporine—Tremor—Capecitabine—colon cancer	0.000107	0.000921	CcSEcCtD
Cyclosporine—Renal failure—Methotrexate—colon cancer	0.000107	0.000921	CcSEcCtD
Cyclosporine—Stomatitis—Methotrexate—colon cancer	0.000106	0.000913	CcSEcCtD
Cyclosporine—Ill-defined disorder—Capecitabine—colon cancer	0.000106	0.000912	CcSEcCtD
Cyclosporine—Urticaria—Fluorouracil—colon cancer	0.000106	0.000912	CcSEcCtD
Cyclosporine—Conjunctivitis—Methotrexate—colon cancer	0.000106	0.000911	CcSEcCtD
Cyclosporine—Anaemia—Capecitabine—colon cancer	0.000106	0.000909	CcSEcCtD
Cyclosporine—Body temperature increased—Fluorouracil—colon cancer	0.000105	0.000908	CcSEcCtD
Cyclosporine—Hypersensitivity—Vincristine—colon cancer	0.000105	0.000907	CcSEcCtD
Cyclosporine—Haematuria—Methotrexate—colon cancer	0.000104	0.000893	CcSEcCtD
Cyclosporine—Malaise—Capecitabine—colon cancer	0.000103	0.000887	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Methotrexate—colon cancer	0.000103	0.000886	CcSEcCtD
Cyclosporine—Epistaxis—Methotrexate—colon cancer	0.000103	0.000884	CcSEcCtD
Cyclosporine—Vertigo—Capecitabine—colon cancer	0.000103	0.000883	CcSEcCtD
Cyclosporine—Hypersensitivity—Irinotecan—colon cancer	0.000103	0.000883	CcSEcCtD
Cyclosporine—Asthenia—Vincristine—colon cancer	0.000103	0.000883	CcSEcCtD
Cyclosporine—Leukopenia—Capecitabine—colon cancer	0.000102	0.00088	CcSEcCtD
Cyclosporine—Asthenia—Irinotecan—colon cancer	0.0001	0.00086	CcSEcCtD
Cyclosporine—Cough—Capecitabine—colon cancer	9.97e-05	0.000858	CcSEcCtD
Cyclosporine—ABCB1—bone marrow—colon cancer	9.91e-05	0.00113	CbGeAlD
Cyclosporine—Hypertension—Capecitabine—colon cancer	9.86e-05	0.000849	CcSEcCtD
Cyclosporine—Hypersensitivity—Fluorouracil—colon cancer	9.83e-05	0.000846	CcSEcCtD
Cyclosporine—Haemoglobin—Methotrexate—colon cancer	9.82e-05	0.000845	CcSEcCtD
Cyclosporine—Diarrhoea—Vincristine—colon cancer	9.79e-05	0.000842	CcSEcCtD
Cyclosporine—Haemorrhage—Methotrexate—colon cancer	9.77e-05	0.000841	CcSEcCtD
Cyclosporine—Hepatitis—Methotrexate—colon cancer	9.77e-05	0.000841	CcSEcCtD
Cyclosporine—Arthralgia—Capecitabine—colon cancer	9.73e-05	0.000837	CcSEcCtD
Cyclosporine—Myalgia—Capecitabine—colon cancer	9.73e-05	0.000837	CcSEcCtD
Cyclosporine—Chest pain—Capecitabine—colon cancer	9.73e-05	0.000837	CcSEcCtD
Cyclosporine—Pharyngitis—Methotrexate—colon cancer	9.7e-05	0.000835	CcSEcCtD
Cyclosporine—Anxiety—Capecitabine—colon cancer	9.69e-05	0.000834	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	9.66e-05	0.000831	CcSEcCtD
Cyclosporine—Urinary tract disorder—Methotrexate—colon cancer	9.65e-05	0.00083	CcSEcCtD
Cyclosporine—Discomfort—Capecitabine—colon cancer	9.61e-05	0.000827	CcSEcCtD
Cyclosporine—Urethral disorder—Methotrexate—colon cancer	9.58e-05	0.000824	CcSEcCtD
Cyclosporine—Diarrhoea—Irinotecan—colon cancer	9.53e-05	0.00082	CcSEcCtD
Cyclosporine—Dry mouth—Capecitabine—colon cancer	9.51e-05	0.000819	CcSEcCtD
Cyclosporine—ABCB1—vagina—colon cancer	9.49e-05	0.00108	CbGeAlD
Cyclosporine—Dizziness—Vincristine—colon cancer	9.46e-05	0.000814	CcSEcCtD
Cyclosporine—Pruritus—Fluorouracil—colon cancer	9.44e-05	0.000813	CcSEcCtD
Cyclosporine—Visual impairment—Methotrexate—colon cancer	9.42e-05	0.00081	CcSEcCtD
Cyclosporine—Confusional state—Capecitabine—colon cancer	9.4e-05	0.000809	CcSEcCtD
Cyclosporine—Oedema—Capecitabine—colon cancer	9.32e-05	0.000803	CcSEcCtD
Cyclosporine—Infection—Capecitabine—colon cancer	9.26e-05	0.000797	CcSEcCtD
Cyclosporine—Dizziness—Irinotecan—colon cancer	9.21e-05	0.000793	CcSEcCtD
Cyclosporine—Nervous system disorder—Capecitabine—colon cancer	9.14e-05	0.000787	CcSEcCtD
Cyclosporine—Diarrhoea—Fluorouracil—colon cancer	9.13e-05	0.000786	CcSEcCtD
Cyclosporine—Thrombocytopenia—Capecitabine—colon cancer	9.13e-05	0.000786	CcSEcCtD
Cyclosporine—Tinnitus—Methotrexate—colon cancer	9.11e-05	0.000784	CcSEcCtD
Cyclosporine—Vomiting—Vincristine—colon cancer	9.1e-05	0.000783	CcSEcCtD
Cyclosporine—Skin disorder—Capecitabine—colon cancer	9.06e-05	0.00078	CcSEcCtD
Cyclosporine—Rash—Vincristine—colon cancer	9.02e-05	0.000776	CcSEcCtD
Cyclosporine—Hyperhidrosis—Capecitabine—colon cancer	9.01e-05	0.000776	CcSEcCtD
Cyclosporine—Dermatitis—Vincristine—colon cancer	9.01e-05	0.000776	CcSEcCtD
Cyclosporine—Headache—Vincristine—colon cancer	8.96e-05	0.000771	CcSEcCtD
Cyclosporine—Anorexia—Capecitabine—colon cancer	8.89e-05	0.000765	CcSEcCtD
Cyclosporine—Angiopathy—Methotrexate—colon cancer	8.86e-05	0.000763	CcSEcCtD
Cyclosporine—Vomiting—Irinotecan—colon cancer	8.86e-05	0.000762	CcSEcCtD
Cyclosporine—Dizziness—Fluorouracil—colon cancer	8.82e-05	0.000759	CcSEcCtD
Cyclosporine—Mediastinal disorder—Methotrexate—colon cancer	8.81e-05	0.000758	CcSEcCtD
Cyclosporine—Rash—Irinotecan—colon cancer	8.78e-05	0.000756	CcSEcCtD
Cyclosporine—Dermatitis—Irinotecan—colon cancer	8.78e-05	0.000755	CcSEcCtD
Cyclosporine—Chills—Methotrexate—colon cancer	8.77e-05	0.000755	CcSEcCtD
Cyclosporine—Headache—Irinotecan—colon cancer	8.73e-05	0.000751	CcSEcCtD
Cyclosporine—Alopecia—Methotrexate—colon cancer	8.63e-05	0.000743	CcSEcCtD
Cyclosporine—Mental disorder—Methotrexate—colon cancer	8.56e-05	0.000737	CcSEcCtD
Cyclosporine—Malnutrition—Methotrexate—colon cancer	8.5e-05	0.000732	CcSEcCtD
Cyclosporine—Nausea—Vincristine—colon cancer	8.5e-05	0.000731	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Capecitabine—colon cancer	8.5e-05	0.000731	CcSEcCtD
Cyclosporine—Vomiting—Fluorouracil—colon cancer	8.48e-05	0.00073	CcSEcCtD
Cyclosporine—Insomnia—Capecitabine—colon cancer	8.43e-05	0.000726	CcSEcCtD
Cyclosporine—Rash—Fluorouracil—colon cancer	8.41e-05	0.000724	CcSEcCtD
Cyclosporine—Dermatitis—Fluorouracil—colon cancer	8.41e-05	0.000723	CcSEcCtD
Cyclosporine—Paraesthesia—Capecitabine—colon cancer	8.37e-05	0.000721	CcSEcCtD
Cyclosporine—Headache—Fluorouracil—colon cancer	8.36e-05	0.000719	CcSEcCtD
Cyclosporine—Dysgeusia—Methotrexate—colon cancer	8.33e-05	0.000717	CcSEcCtD
Cyclosporine—Dyspnoea—Capecitabine—colon cancer	8.31e-05	0.000715	CcSEcCtD
Cyclosporine—Nausea—Irinotecan—colon cancer	8.28e-05	0.000712	CcSEcCtD
Cyclosporine—Dyspepsia—Capecitabine—colon cancer	8.21e-05	0.000706	CcSEcCtD
Cyclosporine—Decreased appetite—Capecitabine—colon cancer	8.11e-05	0.000698	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Capecitabine—colon cancer	8.05e-05	0.000693	CcSEcCtD
Cyclosporine—Fatigue—Capecitabine—colon cancer	8.04e-05	0.000692	CcSEcCtD
Cyclosporine—Vision blurred—Methotrexate—colon cancer	8.02e-05	0.00069	CcSEcCtD
Cyclosporine—ABCB1—liver—colon cancer	8.01e-05	0.00091	CbGeAlD
Cyclosporine—Pain—Capecitabine—colon cancer	7.97e-05	0.000686	CcSEcCtD
Cyclosporine—Constipation—Capecitabine—colon cancer	7.97e-05	0.000686	CcSEcCtD
Cyclosporine—Nausea—Fluorouracil—colon cancer	7.93e-05	0.000682	CcSEcCtD
Cyclosporine—Ill-defined disorder—Methotrexate—colon cancer	7.89e-05	0.000679	CcSEcCtD
Cyclosporine—Anaemia—Methotrexate—colon cancer	7.86e-05	0.000677	CcSEcCtD
Cyclosporine—Feeling abnormal—Capecitabine—colon cancer	7.68e-05	0.000661	CcSEcCtD
Cyclosporine—Malaise—Methotrexate—colon cancer	7.67e-05	0.00066	CcSEcCtD
Cyclosporine—Vertigo—Methotrexate—colon cancer	7.64e-05	0.000658	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Capecitabine—colon cancer	7.62e-05	0.000656	CcSEcCtD
Cyclosporine—Leukopenia—Methotrexate—colon cancer	7.61e-05	0.000655	CcSEcCtD
Cyclosporine—Cough—Methotrexate—colon cancer	7.42e-05	0.000639	CcSEcCtD
Cyclosporine—Urticaria—Capecitabine—colon cancer	7.41e-05	0.000638	CcSEcCtD
Cyclosporine—Abdominal pain—Capecitabine—colon cancer	7.37e-05	0.000634	CcSEcCtD
Cyclosporine—Body temperature increased—Capecitabine—colon cancer	7.37e-05	0.000634	CcSEcCtD
Cyclosporine—Convulsion—Methotrexate—colon cancer	7.37e-05	0.000634	CcSEcCtD
Cyclosporine—Arthralgia—Methotrexate—colon cancer	7.24e-05	0.000623	CcSEcCtD
Cyclosporine—Chest pain—Methotrexate—colon cancer	7.24e-05	0.000623	CcSEcCtD
Cyclosporine—Myalgia—Methotrexate—colon cancer	7.24e-05	0.000623	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	7.19e-05	0.000619	CcSEcCtD
Cyclosporine—Discomfort—Methotrexate—colon cancer	7.15e-05	0.000616	CcSEcCtD
Cyclosporine—Confusional state—Methotrexate—colon cancer	7e-05	0.000602	CcSEcCtD
Cyclosporine—Anaphylactic shock—Methotrexate—colon cancer	6.94e-05	0.000597	CcSEcCtD
Cyclosporine—Infection—Methotrexate—colon cancer	6.9e-05	0.000594	CcSEcCtD
Cyclosporine—Hypersensitivity—Capecitabine—colon cancer	6.87e-05	0.000591	CcSEcCtD
Cyclosporine—Nervous system disorder—Methotrexate—colon cancer	6.81e-05	0.000586	CcSEcCtD
Cyclosporine—Thrombocytopenia—Methotrexate—colon cancer	6.8e-05	0.000585	CcSEcCtD
Cyclosporine—Skin disorder—Methotrexate—colon cancer	6.74e-05	0.00058	CcSEcCtD
Cyclosporine—Hyperhidrosis—Methotrexate—colon cancer	6.71e-05	0.000578	CcSEcCtD
Cyclosporine—Asthenia—Capecitabine—colon cancer	6.69e-05	0.000576	CcSEcCtD
Cyclosporine—Anorexia—Methotrexate—colon cancer	6.62e-05	0.000569	CcSEcCtD
Cyclosporine—Pruritus—Capecitabine—colon cancer	6.6e-05	0.000568	CcSEcCtD
Cyclosporine—Diarrhoea—Capecitabine—colon cancer	6.38e-05	0.000549	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Methotrexate—colon cancer	6.32e-05	0.000544	CcSEcCtD
Cyclosporine—Insomnia—Methotrexate—colon cancer	6.28e-05	0.00054	CcSEcCtD
Cyclosporine—Paraesthesia—Methotrexate—colon cancer	6.23e-05	0.000536	CcSEcCtD
Cyclosporine—Dyspnoea—Methotrexate—colon cancer	6.19e-05	0.000533	CcSEcCtD
Cyclosporine—Somnolence—Methotrexate—colon cancer	6.17e-05	0.000531	CcSEcCtD
Cyclosporine—Dizziness—Capecitabine—colon cancer	6.17e-05	0.000531	CcSEcCtD
Cyclosporine—ABCB1—lymph node—colon cancer	6.14e-05	0.000698	CbGeAlD
Cyclosporine—Dyspepsia—Methotrexate—colon cancer	6.11e-05	0.000526	CcSEcCtD
Cyclosporine—Decreased appetite—Methotrexate—colon cancer	6.03e-05	0.000519	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Methotrexate—colon cancer	5.99e-05	0.000516	CcSEcCtD
Cyclosporine—Fatigue—Methotrexate—colon cancer	5.98e-05	0.000515	CcSEcCtD
Cyclosporine—Pain—Methotrexate—colon cancer	5.94e-05	0.000511	CcSEcCtD
Cyclosporine—Vomiting—Capecitabine—colon cancer	5.93e-05	0.00051	CcSEcCtD
Cyclosporine—Rash—Capecitabine—colon cancer	5.88e-05	0.000506	CcSEcCtD
Cyclosporine—Dermatitis—Capecitabine—colon cancer	5.87e-05	0.000506	CcSEcCtD
Cyclosporine—Headache—Capecitabine—colon cancer	5.84e-05	0.000503	CcSEcCtD
Cyclosporine—Feeling abnormal—Methotrexate—colon cancer	5.72e-05	0.000492	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Methotrexate—colon cancer	5.68e-05	0.000489	CcSEcCtD
Cyclosporine—Nausea—Capecitabine—colon cancer	5.54e-05	0.000477	CcSEcCtD
Cyclosporine—Urticaria—Methotrexate—colon cancer	5.51e-05	0.000475	CcSEcCtD
Cyclosporine—Body temperature increased—Methotrexate—colon cancer	5.49e-05	0.000472	CcSEcCtD
Cyclosporine—Abdominal pain—Methotrexate—colon cancer	5.49e-05	0.000472	CcSEcCtD
Cyclosporine—Hypersensitivity—Methotrexate—colon cancer	5.11e-05	0.00044	CcSEcCtD
Cyclosporine—Asthenia—Methotrexate—colon cancer	4.98e-05	0.000429	CcSEcCtD
Cyclosporine—Pruritus—Methotrexate—colon cancer	4.91e-05	0.000423	CcSEcCtD
Cyclosporine—Diarrhoea—Methotrexate—colon cancer	4.75e-05	0.000409	CcSEcCtD
Cyclosporine—Dizziness—Methotrexate—colon cancer	4.59e-05	0.000395	CcSEcCtD
Cyclosporine—Vomiting—Methotrexate—colon cancer	4.41e-05	0.00038	CcSEcCtD
Cyclosporine—Rash—Methotrexate—colon cancer	4.38e-05	0.000377	CcSEcCtD
Cyclosporine—Dermatitis—Methotrexate—colon cancer	4.37e-05	0.000376	CcSEcCtD
Cyclosporine—Headache—Methotrexate—colon cancer	4.35e-05	0.000374	CcSEcCtD
Cyclosporine—Nausea—Methotrexate—colon cancer	4.12e-05	0.000355	CcSEcCtD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.71e-05	0.00024	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CDKN1A—colon cancer	1.71e-05	0.00024	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.7e-05	0.000239	CbGpPWpGaD
Cyclosporine—PPIA—Disease—NRAS—colon cancer	1.69e-05	0.000238	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—AKT1—colon cancer	1.69e-05	0.000237	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—APC—colon cancer	1.67e-05	0.000234	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—NRAS—colon cancer	1.67e-05	0.000234	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—EP300—colon cancer	1.63e-05	0.000229	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.62e-05	0.000228	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—CTNNB1—colon cancer	1.62e-05	0.000227	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—SRC—colon cancer	1.58e-05	0.000222	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—CDKN1A—colon cancer	1.58e-05	0.000222	CbGpPWpGaD
Cyclosporine—PPIA—Disease—MYC—colon cancer	1.58e-05	0.000221	CbGpPWpGaD
Cyclosporine—PPIA—Disease—TGFB1—colon cancer	1.57e-05	0.000221	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—BRAF—colon cancer	1.57e-05	0.00022	CbGpPWpGaD
Cyclosporine—PPIA—Disease—EGFR—colon cancer	1.54e-05	0.000217	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.53e-05	0.000215	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—NRAS—colon cancer	1.52e-05	0.000214	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—EGFR—colon cancer	1.52e-05	0.000213	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—EP300—colon cancer	1.5e-05	0.000211	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.49e-05	0.000209	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.48e-05	0.000209	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—SRC—colon cancer	1.46e-05	0.000205	CbGpPWpGaD
Cyclosporine—PPIA—Disease—KRAS—colon cancer	1.46e-05	0.000205	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—ABCB1—colon cancer	1.45e-05	0.000204	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—KRAS—colon cancer	1.43e-05	0.000201	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—TYMS—colon cancer	1.43e-05	0.0002	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.42e-05	0.0002	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.42e-05	0.000199	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—FGFR3—colon cancer	1.41e-05	0.000198	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—NRAS—colon cancer	1.41e-05	0.000197	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—PTGS2—colon cancer	1.4e-05	0.000197	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—ABCB1—colon cancer	1.39e-05	0.000196	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—EGFR—colon cancer	1.39e-05	0.000195	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.38e-05	0.000194	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—TYMS—colon cancer	1.37e-05	0.000192	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.37e-05	0.000192	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—PTGS2—colon cancer	1.35e-05	0.000189	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.34e-05	0.000188	CbGpPWpGaD
Cyclosporine—PPIA—Disease—PIK3CA—colon cancer	1.34e-05	0.000188	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.34e-05	0.000188	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—PIK3CA—colon cancer	1.32e-05	0.000185	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—KRAS—colon cancer	1.31e-05	0.000184	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—MYC—colon cancer	1.31e-05	0.000184	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—TGFB1—colon cancer	1.31e-05	0.000184	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—APC—colon cancer	1.29e-05	0.000182	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—PIK3CA—colon cancer	1.29e-05	0.000181	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—EGFR—colon cancer	1.28e-05	0.00018	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.27e-05	0.000179	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.27e-05	0.000178	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CTNNB1—colon cancer	1.25e-05	0.000176	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.24e-05	0.000174	CbGpPWpGaD
Cyclosporine—PPIA—Disease—HRAS—colon cancer	1.24e-05	0.000174	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.24e-05	0.000174	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CDKN1A—colon cancer	1.22e-05	0.000172	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—HRAS—colon cancer	1.22e-05	0.000171	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—BRAF—colon cancer	1.21e-05	0.000171	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—ABCB1—colon cancer	1.21e-05	0.00017	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ODC1—colon cancer	1.21e-05	0.00017	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CHST5—colon cancer	1.21e-05	0.00017	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—KRAS—colon cancer	1.21e-05	0.00017	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—PIK3CA—colon cancer	1.2e-05	0.000169	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.2e-05	0.000169	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—TYMS—colon cancer	1.19e-05	0.000167	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CASP3—colon cancer	1.17e-05	0.000165	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—EP300—colon cancer	1.17e-05	0.000164	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CCND1—colon cancer	1.14e-05	0.000161	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—SRC—colon cancer	1.13e-05	0.000159	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CTNNB1—colon cancer	1.13e-05	0.000159	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—EP300—colon cancer	1.12e-05	0.000158	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.12e-05	0.000157	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—HRAS—colon cancer	1.11e-05	0.000156	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—PIK3CA—colon cancer	1.11e-05	0.000156	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.11e-05	0.000156	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CDKN1A—colon cancer	1.11e-05	0.000155	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.1e-05	0.000155	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.1e-05	0.000154	CbGpPWpGaD
Cyclosporine—PPIA—Disease—AKT1—colon cancer	1.09e-05	0.000154	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—ABCB1—colon cancer	1.09e-05	0.000153	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—NRAS—colon cancer	1.09e-05	0.000153	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.08e-05	0.000152	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—AKT1—colon cancer	1.08e-05	0.000151	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—TYMS—colon cancer	1.07e-05	0.000151	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.06e-05	0.000149	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.05e-05	0.000148	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—EP300—colon cancer	1.05e-05	0.000148	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—AKT1—colon cancer	1.05e-05	0.000148	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ABCB1—colon cancer	1.04e-05	0.000146	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—HRAS—colon cancer	1.03e-05	0.000144	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—SRC—colon cancer	1.02e-05	0.000144	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.02e-05	0.000144	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—FGFR3—colon cancer	1.02e-05	0.000144	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—TYMS—colon cancer	1.02e-05	0.000143	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—MYC—colon cancer	1.02e-05	0.000143	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—TGFB1—colon cancer	1.01e-05	0.000142	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PPARG—colon cancer	1.01e-05	0.000142	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—VEGFA—colon cancer	9.97e-06	0.00014	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—EGFR—colon cancer	9.93e-06	0.00014	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—NRAS—colon cancer	9.85e-06	0.000138	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—AKT1—colon cancer	9.84e-06	0.000138	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PPARG—colon cancer	9.69e-06	0.000136	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ABCB1—colon cancer	9.6e-06	0.000135	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ABCB1—colon cancer	9.52e-06	0.000134	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—TYMS—colon cancer	9.43e-06	0.000132	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	9.4e-06	0.000132	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—APC—colon cancer	9.39e-06	0.000132	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—KRAS—colon cancer	9.38e-06	0.000132	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—TYMS—colon cancer	9.35e-06	0.000131	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.31e-06	0.000131	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MYC—colon cancer	9.17e-06	0.000129	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	9.17e-06	0.000129	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TGFB1—colon cancer	9.15e-06	0.000129	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CASP3—colon cancer	9.11e-06	0.000128	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	9.09e-06	0.000128	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—AKT1—colon cancer	9.08e-06	0.000128	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—EGFR—colon cancer	8.97e-06	0.000126	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCND1—colon cancer	8.87e-06	0.000125	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—BRAF—colon cancer	8.83e-06	0.000124	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CTNNB1—colon cancer	8.78e-06	0.000123	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—PIK3CA—colon cancer	8.62e-06	0.000121	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CDKN1A—colon cancer	8.58e-06	0.00012	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—KRAS—colon cancer	8.47e-06	0.000119	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PPARG—colon cancer	8.44e-06	0.000119	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.31e-06	0.000117	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—PIK3CA—colon cancer	8.3e-06	0.000117	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.25e-06	0.000116	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—EP300—colon cancer	8.16e-06	0.000115	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—HRAS—colon cancer	7.98e-06	0.000112	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTGS2—colon cancer	7.95e-06	0.000112	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—SRC—colon cancer	7.94e-06	0.000111	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.84e-06	0.00011	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PIK3CA—colon cancer	7.79e-06	0.000109	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—VEGFA—colon cancer	7.73e-06	0.000109	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	7.68e-06	0.000108	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—NRAS—colon cancer	7.63e-06	0.000107	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTGS2—colon cancer	7.62e-06	0.000107	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PPARG—colon cancer	7.59e-06	0.000107	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.58e-06	0.000106	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TP53—colon cancer	7.53e-06	0.000106	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.32e-06	0.000103	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PPARG—colon cancer	7.22e-06	0.000101	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—HRAS—colon cancer	7.2e-06	0.000101	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTGS2—colon cancer	7.13e-06	0.0001	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MYC—colon cancer	7.11e-06	9.99e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TGFB1—colon cancer	7.09e-06	9.96e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—AKT1—colon cancer	7.04e-06	9.89e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—EGFR—colon cancer	6.96e-06	9.77e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ABCB1—colon cancer	6.88e-06	9.66e-05	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—AKT1—colon cancer	6.78e-06	9.52e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—TYMS—colon cancer	6.76e-06	9.49e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PPARG—colon cancer	6.68e-06	9.38e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTGS2—colon cancer	6.64e-06	9.32e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PPARG—colon cancer	6.62e-06	9.3e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—EP300—colon cancer	6.61e-06	9.29e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KRAS—colon cancer	6.57e-06	9.23e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.54e-06	9.18e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CTNNB1—colon cancer	6.38e-06	8.96e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—AKT1—colon cancer	6.36e-06	8.93e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—EP300—colon cancer	6.34e-06	8.9e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CDKN1A—colon cancer	6.23e-06	8.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.09e-06	8.55e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PIK3CA—colon cancer	6.04e-06	8.48e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTGS2—colon cancer	5.97e-06	8.39e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.96e-06	8.37e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ABCB1—colon cancer	5.96e-06	8.37e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EP300—colon cancer	5.93e-06	8.33e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—TYMS—colon cancer	5.85e-06	8.22e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—colon cancer	5.84e-06	8.2e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—SRC—colon cancer	5.77e-06	8.1e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTGS2—colon cancer	5.68e-06	7.97e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—HRAS—colon cancer	5.59e-06	7.85e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—NRAS—colon cancer	5.55e-06	7.79e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—EP300—colon cancer	5.52e-06	7.75e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.44e-06	7.64e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ABCB1—colon cancer	5.32e-06	7.47e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTGS2—colon cancer	5.26e-06	7.38e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—TYMS—colon cancer	5.22e-06	7.34e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTGS2—colon cancer	5.21e-06	7.32e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MYC—colon cancer	5.17e-06	7.26e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—TGFB1—colon cancer	5.16e-06	7.24e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—TYMS—colon cancer	5.1e-06	7.16e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EGFR—colon cancer	5.06e-06	7.1e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—EP300—colon cancer	4.97e-06	6.98e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.96e-06	6.96e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—AKT1—colon cancer	4.93e-06	6.93e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ABCB1—colon cancer	4.89e-06	6.87e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CA—colon cancer	4.89e-06	6.87e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ABCB1—colon cancer	4.85e-06	6.81e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—TYMS—colon cancer	4.8e-06	6.75e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PPARG—colon cancer	4.79e-06	6.72e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KRAS—colon cancer	4.78e-06	6.71e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—TYMS—colon cancer	4.76e-06	6.69e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—EP300—colon cancer	4.72e-06	6.63e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CA—colon cancer	4.69e-06	6.59e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.51e-06	6.33e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CA—colon cancer	4.39e-06	6.16e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—EP300—colon cancer	4.37e-06	6.14e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—EP300—colon cancer	4.33e-06	6.09e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PPARG—colon cancer	4.15e-06	5.82e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CA—colon cancer	4.08e-06	5.74e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HRAS—colon cancer	4.06e-06	5.7e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.02e-06	5.65e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—AKT1—colon cancer	4e-06	5.61e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—AKT1—colon cancer	3.83e-06	5.38e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTGS2—colon cancer	3.77e-06	5.29e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PPARG—colon cancer	3.7e-06	5.2e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CA—colon cancer	3.67e-06	5.16e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.67e-06	5.15e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PPARG—colon cancer	3.61e-06	5.07e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—AKT1—colon cancer	3.58e-06	5.03e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CA—colon cancer	3.49e-06	4.9e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PPARG—colon cancer	3.4e-06	4.78e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PPARG—colon cancer	3.37e-06	4.74e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—AKT1—colon cancer	3.34e-06	4.69e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTGS2—colon cancer	3.26e-06	4.58e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CA—colon cancer	3.23e-06	4.54e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CA—colon cancer	3.2e-06	4.5e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ABCB1—colon cancer	3.2e-06	4.49e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—TYMS—colon cancer	3.14e-06	4.41e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—EP300—colon cancer	3.13e-06	4.4e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—AKT1—colon cancer	3e-06	4.22e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTGS2—colon cancer	2.91e-06	4.09e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—AKT1—colon cancer	2.85e-06	4.01e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTGS2—colon cancer	2.84e-06	3.99e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—EP300—colon cancer	2.71e-06	3.81e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTGS2—colon cancer	2.68e-06	3.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTGS2—colon cancer	2.65e-06	3.73e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—AKT1—colon cancer	2.64e-06	3.71e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—AKT1—colon cancer	2.62e-06	3.68e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—EP300—colon cancer	2.42e-06	3.4e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—EP300—colon cancer	2.36e-06	3.32e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CA—colon cancer	2.32e-06	3.25e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—EP300—colon cancer	2.23e-06	3.13e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PPARG—colon cancer	2.23e-06	3.13e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—EP300—colon cancer	2.21e-06	3.1e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CA—colon cancer	2.01e-06	2.82e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—AKT1—colon cancer	1.89e-06	2.66e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CA—colon cancer	1.79e-06	2.52e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTGS2—colon cancer	1.75e-06	2.46e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CA—colon cancer	1.75e-06	2.46e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CA—colon cancer	1.65e-06	2.31e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—AKT1—colon cancer	1.64e-06	2.3e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CA—colon cancer	1.63e-06	2.29e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—AKT1—colon cancer	1.46e-06	2.06e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—EP300—colon cancer	1.46e-06	2.04e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—AKT1—colon cancer	1.43e-06	2.01e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—AKT1—colon cancer	1.35e-06	1.89e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—AKT1—colon cancer	1.33e-06	1.87e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CA—colon cancer	1.08e-06	1.51e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—AKT1—colon cancer	8.8e-07	1.24e-05	CbGpPWpGaD
